{"retracted":false,"update":{"timestamp":1395446400000,"doi":"10.1007/s40259-014-0093-2","type":"correction"},"doi":"10.1007/s40259-013-0056-z","journal":"BioDrugs","publisher":"Springer Nature","title":"Erratum to: Second-Generation Tyrosine Kinase Inhibitors in First-Line Treatment of Chronic Myeloid Leukaemia (CML)"}
